PLI scheme may trigger investments worth Rs 50,000 crore into pharma sector

Major pharma players have warmed up to the bulk drug production-linked incentive (PLI) scheme. According to industry insiders, once the second tranche of the scheme covering formulations comes online, it may trigger investments worth Rs 50,000 crore. 

There are two PLI schemes for the pharma sector — one for bulk drugs, and another covering formulations, biologics, complex generics, etc. 

According to the people, 86 companies have applied to start production of bulk drugs listed under the PLI scheme so far, said sources. “About 86 proposals have gone to the department of pharmaceuticals for 215 molecules in total,” said an industry source. 

Lupin, Cipla,